Integrated High-Efficient Crispr/Cas9-Based Genome Engineering with Non-Invasive Fus-Based Gene Delivery in the Treatment of Parkinson’S Disease: from Model Systems to Human Patients

2022-08-012024-05-13https://scholars.lib.ntu.edu.tw/handle/123456789/653858Integrated High-Efficient Crispr/Cas9-Based Genome Engineering with Non-Invasive Fus-Based Gene Delivery in the Treatment of Parkinson’S Disease: from Model Systems to Human Patients